3-(2,4-Difluorophenyl)-1-(pyridin-4-yl)benzo[4,5]imidazo[1,2-d][1,2,4]triazin-4(3H)-one
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
In: IUCr Data 1.2016, 9
- Ereignis
-
Veröffentlichung
- (wo)
-
Furtwangen
- (wer)
-
Hochschule Furtwangen
- (wann)
-
2016
- Urheber
- DOI
-
10.1107/S2414314616013808
- URN
-
urn:nbn:de:bsz:fn1-opus4-32490
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:26 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Abu Thaher, Bassam
- Schollmeyer, Dieter
- Qeshta, Basem
- Deigner, Hans-Peter
- Hochschule Furtwangen
Entstanden
- 2016
Ähnliche Objekte (12)
![Crystal structures of pure 3-(4-bromo-2-chlorophenyl)-1-(pyridin-4-yl)benzo[4,5]imidazo[1,2-d][1,2,4]triazin-4(3H)-one and contaminated with 3-(4-bromophenyl)-1-(pyridin-4-yl)benzo[4,5]imidazo[1,2-d][1,2,4]triazin-4(3H)-one](/assets/placeholder/searchResultMediaUnknown.png)
Crystal structures of pure 3-(4-bromo-2-chlorophenyl)-1-(pyridin-4-yl)benzo[4,5]imidazo[1,2-d][1,2,4]triazin-4(3H)-one and contaminated with 3-(4-bromophenyl)-1-(pyridin-4-yl)benzo[4,5]imidazo[1,2-d][1,2,4]triazin-4(3H)-one
![Untersuchungen zur Biotransformation und Pharmakokinetik von 4-Oxa-5-(N-methylcarbamoyloxy)-tricyclo-[5.2.1.0.]-dec-8-en-3-on [Oxa-N-methylcarbamoyloxy-tricyclo-dec-en-on] (Lu 253) in der Ratte](/assets/placeholder/searchResultMediaNoDigitisedMedia.png)
Untersuchungen zur Biotransformation und Pharmakokinetik von 4-Oxa-5-(N-methylcarbamoyloxy)-tricyclo-[5.2.1.0.]-dec-8-en-3-on [Oxa-N-methylcarbamoyloxy-tricyclo-dec-en-on] (Lu 253) in der Ratte
1-(Pyridin-4-yl)-3-(2,4,6-trichlorophenyl)benz- [4,5]imidazo[1,2-d ][1,2,4]triazin-4(3H)-one
Derailed Ceramide Metabolism in Atopic Dermatitis (AD): A Causal Starting Point for a Personalized (Basic) Therapy
Preprocessing of gene expression data by optimally robust estimators
Facioscapulohumeral muscular dystrophy: genetics, gene activation and downstream signalling with regard to recent therapeutic approaches: an update
Rapid Phenotypic Antibiotics Susceptibility Analysis by a 3D Printed Prototype
Direct 3D printed biocompatible microfluidics: assessment of human mesenchymal stem cell differentiation and cytotoxic drug screening in a dynamic culture system
Data for homogeneous thermofluorimetric assays for ethanolamine using aptamers and a PCR instrument
Emerging options for the diagnosis of bacterial infections and the characterization of antimicrobial resistance
Synthese und Biokompatibilitätsbewertungen neuartiger, biofunktioneller Polymere für die Medizintechnik
Synthese und biologische Evaluierung von Naturstoffanaloga hinsichtlich ihrer Inhibierung von Cholinesterasen
Crystal structures of pure 3-(4-bromo-2-chlorophenyl)-1-(pyridin-4-yl)benzo[4,5]imidazo[1,2-d][1,2,4]triazin-4(3H)-one and contaminated with 3-(4-bromophenyl)-1-(pyridin-4-yl)benzo[4,5]imidazo[1,2-d][1,2,4]triazin-4(3H)-one
Untersuchungen zur Biotransformation und Pharmakokinetik von 4-Oxa-5-(N-methylcarbamoyloxy)-tricyclo-[5.2.1.0.]-dec-8-en-3-on [Oxa-N-methylcarbamoyloxy-tricyclo-dec-en-on] (Lu 253) in der Ratte
1-(Pyridin-4-yl)-3-(2,4,6-trichlorophenyl)benz- [4,5]imidazo[1,2-d ][1,2,4]triazin-4(3H)-one
Derailed Ceramide Metabolism in Atopic Dermatitis (AD): A Causal Starting Point for a Personalized (Basic) Therapy
Preprocessing of gene expression data by optimally robust estimators
Facioscapulohumeral muscular dystrophy: genetics, gene activation and downstream signalling with regard to recent therapeutic approaches: an update
Rapid Phenotypic Antibiotics Susceptibility Analysis by a 3D Printed Prototype
Direct 3D printed biocompatible microfluidics: assessment of human mesenchymal stem cell differentiation and cytotoxic drug screening in a dynamic culture system
Data for homogeneous thermofluorimetric assays for ethanolamine using aptamers and a PCR instrument
Emerging options for the diagnosis of bacterial infections and the characterization of antimicrobial resistance
Synthese und Biokompatibilitätsbewertungen neuartiger, biofunktioneller Polymere für die Medizintechnik
Synthese und biologische Evaluierung von Naturstoffanaloga hinsichtlich ihrer Inhibierung von Cholinesterasen
Crystal structures of pure 3-(4-bromo-2-chlorophenyl)-1-(pyridin-4-yl)benzo[4,5]imidazo[1,2-d][1,2,4]triazin-4(3H)-one and contaminated with 3-(4-bromophenyl)-1-(pyridin-4-yl)benzo[4,5]imidazo[1,2-d][1,2,4]triazin-4(3H)-one
Untersuchungen zur Biotransformation und Pharmakokinetik von 4-Oxa-5-(N-methylcarbamoyloxy)-tricyclo-[5.2.1.0.]-dec-8-en-3-on [Oxa-N-methylcarbamoyloxy-tricyclo-dec-en-on] (Lu 253) in der Ratte
1-(Pyridin-4-yl)-3-(2,4,6-trichlorophenyl)benz- [4,5]imidazo[1,2-d ][1,2,4]triazin-4(3H)-one
Derailed Ceramide Metabolism in Atopic Dermatitis (AD): A Causal Starting Point for a Personalized (Basic) Therapy
Preprocessing of gene expression data by optimally robust estimators
Facioscapulohumeral muscular dystrophy: genetics, gene activation and downstream signalling with regard to recent therapeutic approaches: an update
Rapid Phenotypic Antibiotics Susceptibility Analysis by a 3D Printed Prototype
Direct 3D printed biocompatible microfluidics: assessment of human mesenchymal stem cell differentiation and cytotoxic drug screening in a dynamic culture system
Data for homogeneous thermofluorimetric assays for ethanolamine using aptamers and a PCR instrument
Emerging options for the diagnosis of bacterial infections and the characterization of antimicrobial resistance
Synthese und Biokompatibilitätsbewertungen neuartiger, biofunktioneller Polymere für die Medizintechnik